Cargando…

Iron Transporters and Ferroptosis in Malignant Brain Tumors

Malignant brain tumors represent approximately 1.5% of all malignant tumors. The survival rate among patients is relatively low and the mortality rate of pediatric brain tumors ranks first among all childhood malignant tumors. At present malignant brain tumors remain incurable. Although some tumors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jingyu, Wang, Yaqi, Tao, Lei, Chen, Ligong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071296/ https://www.ncbi.nlm.nih.gov/pubmed/35530363 http://dx.doi.org/10.3389/fonc.2022.861834

Ejemplares similares

Editorial: Ferroptosis in malignant brain tumors
por: Yakubov, Eduard, et al.
Publicado: (2023)

Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
por: Dahlmanns, Marc, et al.
Publicado: (2021)

Ferroptosis in hematological malignant tumors
por: Liu, Yong, et al.
Publicado: (2023)

Ferroptosis and PPAR-gamma in the limelight of brain tumors and edema
por: Yakubov, Eduard, et al.
Publicado: (2023)

Regulation of iron metabolism and ferroptosis in cancer stem cells
por: Wang, Hailiang, et al.
Publicado: (2023)

Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies
por: Zhao, Yan, et al.
Publicado: (2021)

Iron Regulates the Warburg Effect and Ferroptosis in Colorectal Cancer
por: Yuan, Yin, et al.
Publicado: (2021)

Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors
por: Yao, Yansheng, et al.
Publicado: (2023)

Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
por: Cai, Huazhong, et al.
Publicado: (2023)

Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy
por: Sun, Yonghao, et al.
Publicado: (2022)

Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells
por: Battaglia, Anna Martina, et al.
Publicado: (2022)

From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
por: Grignano, Eric, et al.
Publicado: (2020)

Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment
por: Bi, Qing, et al.
Publicado: (2022)

Effect of tumor microenvironment on ferroptosis: inhibition or promotion
por: Xia, Zhengzhen, et al.
Publicado: (2023)

Ferroptosis: Biochemistry and Biology in Cancers
por: Shi, Zhiyuan, et al.
Publicado: (2021)

Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer
por: Wang, Hong-Tao, et al.
Publicado: (2022)

Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine
por: Yun, Tian, et al.
Publicado: (2022)

Iron homeostasis imbalance and ferroptosis in brain diseases
por: Long, Haining, et al.
Publicado: (2023)

The solute carrier transporters and the brain: Physiological and pharmacological implications
por: Hu, Chengliang, et al.
Publicado: (2020)

Case Report: Malignant Brain Tumors in Siblings With MSH6 Mutations
por: Wu, Di, et al.
Publicado: (2022)

Targeting MYCN in Molecularly Defined Malignant Brain Tumors
por: Borgenvik, Anna, et al.
Publicado: (2021)

Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
por: Cifarelli, Christopher P., et al.
Publicado: (2021)

A stratification system of ferroptosis and iron-metabolism related LncRNAs guides the prediction of the survival of patients with esophageal squamous cell carcinoma
por: Niu, Ren, et al.
Publicado: (2022)

Ferroptosis: Redox Imbalance and Hematological Tumorigenesis
por: Lan, Hongying, et al.
Publicado: (2022)

Photodynamic therapy for malignant brain tumors in children and young adolescents
por: Chiba, Kentaro, et al.
Publicado: (2022)

Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease
por: Lin, Kai-Jung, et al.
Publicado: (2022)

Emerging roles of ferroptosis in glioma
por: Shi, Jiaqi, et al.
Publicado: (2022)

Differentiation of malignant brain tumor types using intratumoral and peritumoral radiomic features
por: Liu, Dongming, et al.
Publicado: (2022)

Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
por: Dutoit, Valérie, et al.
Publicado: (2016)

Corrigendum: Photodynamic therapy for malignant brain tumors in children and young adolescents
por: Chiba, Kentaro, et al.
Publicado: (2023)

Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020)

Lipid droplets and ferroptosis as new players in brain cancer glioblastoma progression and therapeutic resistance
por: Bezawork-Geleta, Ayenachew, et al.
Publicado: (2022)

Iron Metabolism in Ferroptosis
por: Chen, Xin, et al.
Publicado: (2020)

Ferroptosis regulator NOS2 is closely associated with the prognosis and cell malignant behaviors of hepatoblastoma: a bioinformatic and in vitro study
por: Zhang, Lan, et al.
Publicado: (2023)

Autophagy-related prognostic signature characterizes tumor microenvironment and predicts response to ferroptosis in gastric cancer
por: Li, Haoran, et al.
Publicado: (2022)

Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer
por: Wang, Song, et al.
Publicado: (2022)

Autophagy-dependent ferroptosis as a potential treatment for glioblastoma
por: Xie, Yangchun, et al.
Publicado: (2023)

Ferroptosis in osteosarcoma: A promising future
por: Liu, Xiang, et al.
Publicado: (2022)

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
por: Zhu, Jingjuan, et al.
Publicado: (2023)

ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies
por: Chen, Jingyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ma2n81qb91lpc4p7hk912qaev6